person · Reporting owner
General Atlantic Cooperatief U.A.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Centessa Pharmaceuticals plcCNTA · Entity 35581 | Director · 10% owner | June 22, 2023 | June 26, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Centessa Pharmaceuticals plc
Report date June 22, 2023 · Filed June 26, 2023
Jointly reported with GAP (Bermuda) L.P., GENERAL ATLANTIC GENPAR (BERMUDA), L.P., General Atlantic (Lux) S.a r.l., General Atlantic GenPar (Lux) SCSp, General Atlantic Cooperatief, L.P., General Atlantic Partners (Lux), SCSp, General Atlantic Partners (Bermuda) EU, L.P., General Atlantic Partners (Bermuda) IV, L.P., General Atlantic UM B.V.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.35 · Expires 2023-06-22 | IndirectSee footnote | 48,000 |
Reported balance
After 2023-06-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-22 · Grant · Acquired 48,000 · Balance 48,000 F1: The Ordinary Shares subject to the Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to Dr. Brett Zbar's continued service as a director of the Issuer through the applicable vesting date. F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3: The Share Option was granted to Dr. Zbar who is an employee of General Atlantic Service Company, L.P., a Delaware limited partnership ("GASC ") and director of the Issuer. F4: The Share Option granted to Dr. Zbar is held by him solely for the benefit of GASC, which is controlled by the management committee of GASC MGP, LLC (the "Management Committee"). There are eleven members of the Management Committee. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares subject to the Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to Dr. Brett Zbar's continued service as a director of the Issuer through the applicable vesting date.
F2: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F3: The Share Option was granted to Dr. Zbar who is an employee of General Atlantic Service Company, L.P., a Delaware limited partnership ("GASC ") and director of the Issuer.
F4: The Share Option granted to Dr. Zbar is held by him solely for the benefit of GASC, which is controlled by the management committee of GASC MGP, LLC (the "Management Committee"). There are eleven members of the Management Committee. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2023 Filed Jun 26, 2023 23:03 UTC | Centessa Pharmaceuticals plc CNTA · Entity 35581 | GrantShare Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $6.35 | $0.00 |
DisclosureSEC source: 0000950142-23-001814 · es230373839_4-cnta.xml · derivative · entry 1 GAP (Bermuda) L.P. · CIK 0001406817 · Director · 10% owner GENERAL ATLANTIC GENPAR (BERMUDA), L.P. · CIK 0001467927 · Director · 10% owner General Atlantic (Lux) S.a r.l. · CIK 0001858361 · Director · 10% owner General Atlantic GenPar (Lux) SCSp · CIK 0001857517 · Director · 10% owner General Atlantic Cooperatief, L.P. · CIK 0001859299 · Director · 10% owner General Atlantic Partners (Lux), SCSp · CIK 0001795410 · Director · 10% owner General Atlantic Partners (Bermuda) EU, L.P. · CIK 0001701754 · Director · 10% owner General Atlantic Partners (Bermuda) IV, L.P. · CIK 0001704977 · Director · 10% owner General Atlantic Cooperatief U.A. · CIK 0001859266 · Director · 10% owner General Atlantic UM B.V. · CIK 0001859260 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2023-06-22 F1 · derivative.exercise_date: The Ordinary Shares subject to the Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to Dr. Brett Zbar's continued service as a director of the Issuer through the applicable vesting date. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.nature: The Share Option was granted to Dr. Zbar who is an employee of General Atlantic Service Company, L.P., a Delaware limited partnership ("GASC ") and director of the Issuer. F4 · ownership.nature: The Share Option granted to Dr. Zbar is held by him solely for the benefit of GASC, which is controlled by the management committee of GASC MGP, LLC (the "Management Committee"). There are eleven members of the Management Committee. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 23:03 UTC | Centessa Pharmaceuticals plc CNTA · Entity 35581 | GrantShare Option (right to buy) · Derivative | 48,000 | $0.00 Strike: $4.87 | $0.00 |
DisclosureSEC source: 0000950142-22-002094 · es220267470_4-centessa.xml · derivative · entry 1 GAP (Bermuda) L.P. · CIK 0001406817 · 10% owner GENERAL ATLANTIC GENPAR (BERMUDA), L.P. · CIK 0001467927 · 10% owner General Atlantic (Lux) S.a r.l. · CIK 0001858361 · 10% owner General Atlantic GenPar (Lux) SCSp · CIK 0001857517 · 10% owner General Atlantic Cooperatief, L.P. · CIK 0001859299 · 10% owner General Atlantic Partners (Lux), SCSp · CIK 0001795410 · Director · 10% owner General Atlantic Partners (Bermuda) EU, L.P. · CIK 0001701754 · Director · 10% owner General Atlantic Partners (Bermuda) IV, L.P. · CIK 0001704977 · 10% owner General Atlantic Cooperatief U.A. · CIK 0001859266 · 10% owner General Atlantic UM B.V. · CIK 0001859260 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 48,000 Underlying: Ordinary Shares · 48,000 shares Expires 2032-06-30 F1 · derivative.exercise_date: The Ordinary Shares subject to the Share Option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to Dr. Brett Zbar's continued service as a director of the Issuer through the applicable vesting date. F2 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F3 · ownership.nature: The Share Option was granted to Dr. Zbar who is an employee of General Atlantic Service Company, L.P., a Delaware limited partnership ("GASC ") and director of the Issuer. F4 · ownership.nature: The Share Option granted to Dr. Zbar is held by him solely for the benefit of General Atlantic Service Company, L.P., which is controlled by the management committee of GASC MGP, LLC (the "Management Committee"). There are nine members of the Management Committee. Each of the members of the Management Committee disclaims ownership of the shares except to the extent that he has a pecuniary interest therein. Read SEC document |
| June 02, 2021 Filed Jun 3, 2021 16:24 UTC | Centessa Pharmaceuticals plc CNTA · Entity 35581 | PurchaseADSs | 1,500,000 | $20.00 | $30,000,000.00 |
DisclosureSEC source: 0000950142-21-001839 · es210157235_4-centessa.xml · nonDerivative · entry 1 GAP (Bermuda) LTD · CIK 0001406817 · 10% owner GENERAL ATLANTIC GENPAR (BERMUDA), L.P. · CIK 0001467927 · 10% owner General Atlantic (Lux) S.a r.l. · CIK 0001858361 · 10% owner General Atlantic GenPar (Lux) SCSp · CIK 0001857517 · 10% owner General Atlantic Cooperatief, L.P. · CIK 0001859299 · 10% owner General Atlantic Partners (Lux), SCSp · CIK 0001795410 · Director · 10% owner General Atlantic Partners (Bermuda) EU, L.P. · CIK 0001701754 · Director · 10% owner General Atlantic Partners (Bermuda) IV, L.P. · CIK 0001704977 · 10% owner General Atlantic Cooperatief U.A. · CIK 0001859266 · 10% owner General Atlantic UM B.V. · CIK 0001859260 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681,818 F1 · kind: The American Depositary Shares ("ADSs"), each ADS representing one ordinary share of Centessa Pharmaceuticals Limited (the "Issuer"), were acquired by General Atlantic UM B.V. ("GA UM") in connection with the initial public offering of the Issuer which closed on June 2, 2021. F2 · ownership.direct: Reflects securities held directly by GA UM. GA UM is a wholly owned subsidiary of General Atlantic Cooperatief U.A. ("GA Coop UA"). The members that share beneficial ownership of the shares held by GA UM through GA Coop UA are the following General Atlantic investment funds (the "GA Funds"): General Atlantic Partners (Bermuda) IV, L.P. ("GAP Bermuda IV"), General Atlantic Partners (Bermuda) EU, L.P. ("GAP Bermuda EU"), General Atlantic Partners (Lux) SCSp ("GAP Lux") and General Atlantic Cooperatief, L.P. ("GA Coop LP"). F3 · ownership.direct: The general partner of GAP Lux is General Atlantic GenPar (Lux) SCSp ("GA GenPar Lux") and the general partner of GA GenPar Lux is General Atlantic (Lux) S.a r.l. ("GA Sarl"). The general partner of GAP Bermuda IV and GAP Bermuda EU and the sole shareholder of GA Sarl is General Atlantic GenPar (Bermuda), L.P. ("GenPar Bermuda"). GAP (Bermuda) Limited ("GAP (Bermuda)") is the general partner of GenPar Bermuda and GA Coop LP. There are nine members of the Management Committee of GAP (Bermuda) (the "GA Management Committee"). Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.